Download original image

Fig. 1. Progression-free survival (PFS) among primary central nervous system lymphoma (PCNSL) patients receiving ≥2 treatment cycles vs. those who underwent early discontinuation.

Blood Res 2018;53:174~177 https://doi.org/10.5045/br.2018.53.2.174